Search

everythinglearnresearchcommunity

for

Search:↓

Blood removal and birth control pills both helped with hormone levels in women with PCOS, but birth control was better for regular periods and blood removal had fewer side effects.

AGA patients have higher heart disease risk.

Transdermal testosterone can improve sexual desire in postmenopausal women but lacks long-term safety data and is not FDA-approved for this use.

Vitamin D may help reduce antibody levels in men with autoimmune thyroiditis and early-onset androgenic alopecia, but has no significant impact on thyroid function.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

Hair loss may signal metabolic problems and increased risk of heart disease, suggesting people with hair loss should be checked for these issues.

Leydig cell tumors can cause high testosterone and symptoms like hair loss in postmenopausal women, but surgery can improve these symptoms.

Men can have genetic risks for PCOS-related traits like obesity and diabetes.

Female hair loss is often hereditary and can be treated with medication, hair transplants, and lasers.

The document concludes that insulin resistance is key in PCOS development and early treatment is crucial to prevent complications.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Women with type 1 diabetes often have polycystic ovary syndrome and excess male hormones, which are frequently undiagnosed.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Flutamide works better than finasteride for hirsutism, and combining both is slightly better but not much.

The study suggests certain ACE gene variations are more common in women with PCOS and may be linked to increased insulin resistance.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

Early treatment and lifestyle changes are important for managing PCOS in young people to prevent long-term health issues.

The document concludes that managing PCOS involves treating symptoms, regulating periods, and reducing health risks, with specific medications for fertility and metabolic issues.

Greek women with classic PCOS are more likely to have metabolic syndrome and insulin resistance than those with newer PCOS types.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.

High testosterone levels in 20% of the women studied may indicate PCOS, while 80% had low levels with potential health impacts.

Eating nuts, chocolate candy, and red tea might worsen acne, while eating more fresh vegetables could reduce it.

The document suggests new ways to assess and diagnose hyperandrogenism to improve accuracy.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

Polycystic ovary syndrome is a complex condition that affects women's mental, reproductive, and metabolic health throughout their lives.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.